Total Voting Rights
Fusion Antibodies plc has announced that its total issued share capital comprises 125,156,878 ordinary shares of 4 pence each, with no shares held in treasury, resulting in a total of 125,156,878 voting rights. This figure serves as the denominator for shareholders to calculate their notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Select text to share a quote on X · sign in to keep highlights & notes in your FAB notes
Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces that the issued share capital of the Company at the date of this announcement comprises 125,156,878 ordinary shares of 4 pence each with one voting right per share ("Ordinary Shares"). The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company is 125,156,878.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.